Expression of KIT receptor tyrosine kinase protein in normal human skin: Preliminary observations

Cell Biology International

Volumn 31, Issue 7, 2007, Pages 748-751

  Hussein, Mahmoud R ^a  

^a Assiut University   (Egypt)

Author keywords

Keratinocytes; Kit; Melanocytes; Skin

Indexed keywords

IMATINIB; PROTEIN TYROSINE KINASE; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; BLOOD VESSEL; CELL TYPE; CONTROLLED STUDY; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; KERATINOCYTE; MALE; MAST CELL; MELANOCYTE; MUSCLE CELL; PROTEIN EXPRESSION; SEBACEOUS GLAND; SIGNAL TRANSDUCTION; SKIN; SWEAT GLAND; TISSUE SECTION;

FEMALE; HUMANS; MALE; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR PROTEIN-TYROSINE KINASES; SKIN; TISSUE DISTRIBUTION;

EID: 34248591594     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.12.006     Document Type: Article

References (23)

1. Adly M.A., Assaf H.A., and Hussein M.R. Expression of bone morphogenetic protein-7 in human scalp skin and hair follicles. Br J Dermatol 154 (2006) 551-554
2. Adly M.A., Assaf H.A., and Hussein M.R. Expression of the heat shock protein-27 in the adult human scalp skin and hair follicle: hair cycle-dependent changes. J Am Acad Dermatol 54 (2006) 811-817
3. Adly M.A., Assaf H.A., Hussein M.R., and Neuber K. Age-associated decrease of CD1d protein production in normal human skin. Br J Dermatol 155 (2006) 186-191
4. Botchkareva N.V., Khlgatian M., Longley B.J., Botchkarev V.A., and Gilchrest B.A. SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit. FASEB J 15 (2001) 645-658
5. Curtin J.A., Busam K., Pinkel D., and Bastian B.C. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24 (2006) 4340-4346
6. Dippel E., Haas N., Grabbe J., Schadendorf D., Hamann K., and Czarnetzki B.M. Expression of the c-kit receptor in hypomelanosis: a comparative study between piebaldism, naevus depigmentosus and vitiligo. Br J Dermatol 132 (1995) 182-189
7. Hussein M.R., Roggero E., Sudilovsky E.C., Tuthill R.J., Wood G.S., and Sudilovsky O. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas. Am J Dermatopathol 23 (2001) 308-314
8. Isabel Zhu Y., and Fitzpatrick J.E. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma. J Cutan Pathol 33 (2006) 33-37
9. Kumamoto T., Shalhevet D., Matsue H., Mummert M.E., Ward B.R., Jester J.V., et al. Hair follicles serve as local reservoirs of skin mast cell precursors. Blood 102 (2003) 1654-1660
10. McGary E.C., Onn A., Mills L., Heimberger A., Eton O., Thomas G.W., et al. Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo. J Invest Dermatol 122 (2004) 400-405
11. Miettinen M., and Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13 (2005) 205-220
12. Mino M., Pilch B.Z., and Faquin W.C. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol 16 (2003) 1224-1231
13. Montone K.T., van Belle P., Elenitsas R., and Elder D.E. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Mod Pathol 10 (1997) 939-944
14. Morita E., Lee D.G., Sugiyama M., and Yamamoto S. Expression of c-kit ligand in human keratinocytes. Arch Dermatol Res 286 (1994) 273-277
15. Natali P.G., Nicotra M.R., Winkler A.B., Cavaliere R., Bigotti A., and Ullrich A. Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor. Int J Cancer 52 (1992) 197-201
16. Sakata S., Sakamaki K., Watanabe K., Nakamura N., Toyokuni S., Nishimune Y., et al. Involvement of death receptor Fas in germ cell degeneration in gonads of Kit-deficient Wv/Wv mutant mice. Cell Death Differ 10 (2003) 676-686
17. Sharov A.A., Li G.Z., Palkina T.N., Sharova T.Y., Gilchrest B.A., and Botchkarev V.A. Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss. J Invest Dermatol 120 (2003) 27-35
18. Stefanou D., Batistatou A., Zioga A., Arkoumani E., Papachristou D.J., and Agnantis N.J. Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions. Int J Surg Pathol 12 (2004) 133-138
19. Tsuura Y., Hiraki H., Watanabe K., Igarashi S., Shimamura K., Fukuda T., et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch 424 (1994) 135-141
20. Ugurel S., Hildenbrand R., Zimpfer A., La Rosee P., Paschka P., Sucker A., et al. Lack of clinical efficacy of imatinib in metastatic melanoma. Br J Cancer 92 (2005) 1398-1405
21. Wedemeyer J., and Galli S.J. Decreased susceptibility of mast cell-deficient Kit(W)/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Lab Invest 85 (2005) 388-396
22. Weiss R.R., Whitaker-Menezes D., Longley J., Bender J., and Murphy G.F. Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 104 (1995) 101-106
23. Wyman K., Atkins M.B., Prieto V., Eton O., McDermott D.F., Hubbard F., et al. Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy. Cancer 106 (2006) 2005-2011